MARKET

INVA

INVA

Innoviva
NASDAQ

Real-time Quotes | Nasdaq Last Sale

12.04
-0.12
-0.99%
Opening 13:00 11/14 EST
OPEN
12.16
PREV CLOSE
12.16
HIGH
12.16
LOW
11.98
VOLUME
109.73K
TURNOVER
--
52 WEEK HIGH
20.54
52 WEEK LOW
10.03
MARKET CAP
1.22B
P/E (TTM)
3.638
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of INVA and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 2 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

INVA News

  • Surging Earnings Estimates Signal Upside for Innoviva (INVA) Stock
  • Zacks.1d ago
  • Value ETFs & Stocks Offering Real Value: 5 Top Picks
  • Zacks.2d ago
  • Innoviva EPS beats by $0.03, beats on revenue
  • seekingalpha.10/31 02:01
  • Innoviva Q3 EPS $0.36 Down From $0.43 YoY, Sales $65.755M Up From $61.68M YoY
  • Benzinga.10/30 21:08

More

Industry

Pharmaceuticals
-0.58%
Pharmaceuticals & Medical Research
-0.46%

Hot Stocks

Name
Price
%Change

About INVA

Innoviva, Inc., formerly Theravance, Inc., is engaged in the development, commercialization and financial management of bio-pharmaceuticals. It focuses on the respiratory assets partnered with Glaxo Group Limited (GSK), including RELVAR/BREO ELLIPTA (fluticasone furoate (FF)/vilanterol (VI)) and ANORO ELLIPTA (umeclidinium bromide/vilanterol (UMEC/VI)). Under the Long-Acting Beta2 Agonist (LABA) Collaboration Agreement and the Strategic Alliance Agreement with GSK, the Company is eligible to receive the annual royalties from GSK on sales of RELVAR/BREO ELLIPTA. For other products combined with a LABA from the LABA collaboration, such as ANORO ELLIPTA, royalties are upward tiering and range from 6.5% to 10%. RELVAR/BREO is a once-a-day combination inhaled respiratory medicine consisting of a LABA (VI) and an inhaled corticosteroid (ICS), FF. ANORO ELLIPTA a once-daily medicine combining a long-acting muscarinic antagonist (LAMA), umeclidinium bromide (UMEC), with a LABA.
More

Webull offers Innoviva Inc (INVA) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.